Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1593, Issue 1, 2002, Pages 45-55

  Wang, Zeping ^a   Bhattacharya, Nandini ^a   Mixter, Philip F ^a   Wei, Wenyi ^b   Sedivy, John ^b   Magnuson, Nancy S ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Cell cycle inhibitor p21Cip1 WAF1; Oncogene; Phosphorylation; Protein kinase

Indexed keywords

ARGINYLLYSYLARGINYLARGINYLGLUTAMINYLTHREONYLSERYLMETHIONINE; CYCLIN DEPENDENT KINASE INHIBITOR; PEPTIDE FRAGMENT; PHORBOL ESTER; PHOSPHOAMINO ACID; PROTEIN KINASE PIM 1; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STRAIN U937; CELLULAR DISTRIBUTION; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOPLASM; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WILD TYPE;

CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; MUTATION; PHOSPHORYLATION; PRECIPITIN TESTS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-PIM-1; SUBSTRATE SPECIFICITY;

EID: 0037121534     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(02)00347-6     Document Type: Article

References (63)

1. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512.
2. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
3. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
4. Waga S., Hannon G.J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:1994;574-578.
5. Shivji M.K., Grey S.J., Strausfeld U.P., Wood R.D., Blow J.J. Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Curr. Biol. 4:1994;1062-1068.
6. Harada K., Ogden G.R. An overview of the cell cycle arrest protein, p21 (WAF1). Oral Oncol. 36:2000;3-7.
7. Boulaire J., Fotedar A., Fotedar R. The functions of the cdk-cyclin kinase inhibitor p21WAF1. Pathol. Biol. (Paris). 48:2000;190-202.
8. Dotto G.P. p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta. 1471:2000;M43-M56.
9. Kitaura H., Shinshi M., Uchikoshi Y., Ono T., Iguchi-Ariga S.M., Ariga H. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J. Biol. Chem. 275:2000;10477-10483.
10. Delavaine L., La Thangue N.B. Control of E2F activity by p21Waf1/Cip1. Oncogene. 18:1999;5381-5392.
11. Timchenko N.A., Harris T.E., Wilde M., Bilyeu T.A., Burgess-Beusse B.L., Finegold M.J., Darlington G.J. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice. Mol. Cell. Biol. 17:1997;7353-7361.
12. Coqueret O., Gascan H. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J. Biol. Chem. 275:2000;18794-18800.
13. Suzuki A., Tsutomi Y., Akahane K., Araki T., Miura M. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene. 17:1998;931-939.
14. Shim J., Lee H., Park J., Kim H., Choi E.J. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature. 381:1996;804-806.
15. Asada M., Yamada T., Ichijo H., Delia D., Miyazono K., Fukumuro K., Mizutani S. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18:1999;1223-1234.
16. Estanyol J.M., Jaumot M., Casanovas O., Rodriguez-Vilarrupla A., Agell N., Bachs O. The protein SET regulates the inhibitory effect of p21(Cip1) on cyclin E-cyclin-dependent kinase 2 activity. J. Biol. Chem. 274:1999;33161-33165.
17. Taules M., Rodriguez-Vilarrupla A., Rius J.M., Estanyol E., Casanovas O., Sacks D.B., Perez-Paya E., Bachs O., Agell N. Calmodulin binds to p21(Cip1) and is involved in the regulation of its nuclear localization. J. Biol. Chem. 274:1999;24445-24448.
18. Funk J.O., Waga S., Harry J.B., Espling E., Stillman B., Galloway D.A. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11:1997;2090-2100.
19. Kearsey J.M., Coates P.J., Prescott A.R., Warbrick E., Hall P.A. Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. Oncogene. 11:1995;1675-1683.
20. Ono T., Kitaura H., Ugai H., Murata T., Yokoyama K.K., Iguchi-Ariga S.M., Ariga H. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase. J. Biol. Chem. 275:2000;31145-31154.
21. Gotz C., Wagner P., Issinger O.G., Montenarh M. p21WAF1/CIP1 interacts with protein kinase CK2. Oncogene. 13:1996;391-398.
22. Cuypers H.T., Selten G., Quint W., Zijlstra M., Maandag E.R., Boelens W., van Wezenbeek P., Melief C., Berns A. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell. 37:1984;141-150.
23. Breuer M., Slebos R., Verbeek S., van Lohuizen M., Wientjens E., Berns A. Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice. Nature. 340:1989;61-63.
24. Selten G., Cuypers H.T., Boelens W., Robanus-Maandag E., Verbeek J., Domen J., van Beveren C., Berns A. The primary structure of the putative oncogene pim-1 shows extensive homology with protein kinases. Cell. 46:1986;603-611.
25. van Lohuizen M., Verbeek S., Krimpenfort P., Domen J., Saris C., Radaszkiewicz T., Berns A. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell. 56:1989;673-682.
26. Moroy T., Verbeek S., Ma A., Achacoso P., Berns A., Alt F. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice. Oncogene. 6:1991;1941-1948.
27. Acton D., Domen J., Jacobs H., Vlaar M., Korsmeyer S., Berns A. Collaboration of pim-1 and bcl-2 in lymphomagenesis. Curr. Top. Microbiol. Immunol. 182:1992;293-298.
28. Schmidt T., Karsunky H., Gau E., Zevnik B., Elsasser H.P., Moroy T. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis. Oncogene. 17:1998;2661-2667.
29. Wang Z., Bhattacharya N., Weaver M., Petersen K., Gapter L., Magnuson N.S. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J. Vet. Sci. 2:2001;167-179.
30. Zhu N., Ramirez L.M., Lee R.L., Magnuson N.S., Bishop G.A., Gold M.R. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-kappa B pathway. J. Immunol. 168:2002;744-754.
31. Hoover D., Friedmann M., Reeves R., Magnuson N.S. Recombinant human pim-1 protein exhibits serine/threonine kinase activity. J. Biol. Chem. 266:1991;14018-14023.
32. Palaty C.K., Clark-Lewis I., Leung D., Pelech S.L. Phosphorylation site substrate specificity determinants for the Pim-1 protooncogene-encoded protein kinase. Biochem. Cell. Biol. 75:1997;153-162.
33. Leverson J.D., Koskinen P.J., Orrico F.C., Rainio E.M., Jalkanen K.J., Dash A.B., Eisenman R.N., Ness S.A. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol. Cell. 2:1998;417-425.
34. Mochizuki T., Kitanaka C., Noguchi K., Muramatsu T., Asai A., Kuchino Y. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J. Biol. Chem. 274:1999;18659-18666.
35. Koike N., Maita H., Taira T., Ariga H., Iguchi-Ariga S.M. Identification of heterochromatin protein 1 (HP1) as a phosphorylation target by pim-1 kinase and the effect of phosphorylation on the transcriptional repression function of HP1. FEBS Lett. 467:2000;17-21.
36. Maita H., Harada Y., Nagakubo D., Kitaura H., Ikeda M., Tamai K., Takahashi K., Ariga H., Iguchi-Ariga S.M. PAP-1, a novel target protein of phosphorylation by pim-1 kinase. Eur. J. Biochem. 267:2000;5168-5178.
37. Wang Z., Bhattacharya N., Meyer M.K., Seimiya H., Tsuruo T., Magnuson N.S. Pim-1 negatively regulates the activity of ptp-u2s phosphatase and influences terminal differentiation and apoptosis of monoblastoid leukemia cells. Arch. Biochem. Biophys. 390:2001;9-18.
38. Rainio E.M., Sandholm J., Koskinen P.J. Cutting edge: transcriptional activity of NFATc1 is enhanced by the Pim-1 kinase. J. Immunol. 168:2002;1524-1527.
39. Ishibashi Y., Maita H., Yano M., Koike N., Tamai K., Ariga H., Iguchi-Ariga S.M. Pim-1 translocates sorting nexin 6/TRAF4-associated factor 2 from cytoplasm to nucleus. FEBS Lett. 506:2001;33-38.
40. Bhattacharya N., Wang Z., Davitt C., McKenzie I.F., Xing P.X., Magnuson N.S. Pim-1 associates with protein complexes necessary for mitosis. Chromosoma. 111:2002;80-95.
41. Wei W., Hemmer R.M., Sedivy J.M. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21:2001;6748-6757.
42. Friedmann M., Nissen M.S., Hoover D.S., Reeves R., Magnuson N.S. Characterization of the proto-oncogene pim-1: kinase activity and substrate recognition sequence. Arch. Biochem. Biophys. 298:1992;594-601.
43. Olnes M.I., Kurl R.N. Isolation of nuclear extracts from fragile cells: a simplified procedure applied to thymocytes. Biotechniques. 17:1994;828-829.
44. Cooper J.A., Sefton B.M., Hunter T. Detection and quantification of phosphotyrosine in proteins. Methods Enzymol. 99:1983;387-402.
45. Boyle W.J., van der Geer G.P., Hunter T. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:1991;110-149.
46. Scott M.T., Morrice N., Ball K.L. Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding. J. Biol. Chem. 275:2000;11529-11537.
47. Zhou B.P., Liao Y., Xia W., Spohn B., Lee M.H., Hung M.C. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3:2001;245-252.
48. Rousseau D., Cannella D., Boulaire J., Fitzgerald P., Fotedar A., Fotedar R. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene. 18:1999;4313-4325.
49. Sasaki K., Ikeda K., Nagai M., Shima H., Nagao M., Takahara J., Irino S. Protein phosphatase 2A alpha involvement in granulocytic differentiation of HL-60 cells. Hematol. Oncol. 11:1993;1-5.
50. Omay S.B., Ogasawara H., Toyoda H., Nakai K., Shima H., Nagao M., Mumby M.C., Shiku H., Nishikawa M. Translocation of protein phosphatase 1 catalytic subunits during 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL-60 cells. Cancer Res. 55:1995;774-780.
51. Faulkner N.E., Hilfinger J.M., Markovitz D.M. Protein phosphatase 2A activates the HIV-2 promoter through enhancer elements that include the pets site. J. Biol. Chem. 276:2001;25804-25812.
52. Erhardt J.A., Pittman R.N. Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J. Biol. Chem. 273:1998;23517-23523.
53. Cayrol C., Ducommun B. Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21. Oncogene. 17:1998;2437-2444.
54. Suzuki A., Kawano H., Hayashida M., Hayasaki Y., Tsutomi Y., Akahane K. Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A. Cell Death Differ. 7:2000;721-728.
55. Kriwacki R.W., Hengst L., Tennant L., Reed S.I., Wright P.E. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. U. S. A. 93:1996;11504-11509.
56. Toker A. Signaling through protein kinase C. Front. Biosci. 3:1998;D1134-D1147.
57. Feliciello A., Gottesman M.E., Avvedimento E.V. The biological functions of A-kinase anchor proteins. J. Mol. Biol. 308:2001;99-114.
58. Alessi D.R., Deak M., Casamayor A., Caudwell F.B., Morrice N., Norman D.G., Gaffney P., Reese C.B., MacDougall C.N., Harbison D., Ashworth A., Bownes M. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr. Biol. 7:1997;776-789.
59. Stokoe D., Stephens L.R., Copeland T., Gaffney P.R., Reese C.B., Painter G.F., Holmes A.B., McCormick F., Hawkins P.T. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science. 277:1997;567-570.
60. Filippa N., Sable C.L., Hemmings B.A., Van Obberghen E. Effect of phosphoinositide-dependent kinase 1 on protein kinase B translocation and its subsequent activation. Mol. Cell. Biol. 20:2000;5712-5721.
61. Nishikawa K., Toker A., Johannes F.J., Songyang Z., Cantley L.C. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272:1997;952-960.
62. Alessi D.R., Caudwell F.B., Andjelkovic M., Hemmings B.A., Cohen P. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 399:1996;333-338.
63. Walker K.S., Deak M., Paterson A., Hudson K., Cohen P., Alessi D.R. Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem. J. 331(Pt 1):1998;299-308.